Schott Pharma’s €935m IPO

Freshfields advised Schott Pharma on its IPO. Schott Pharma AG & Co. KGaA has successfully completed its initial public offering. The shares debuted on the regulated...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

AmerisourceBergen’s $1,3 Billion Acquisition of PharmaLex

Noerr advised AUCTUS, while Freshfields Bruckhaus Deringer advised AmerisourceBergen Corporation. McDermott Will & Emery, Buntscheck and Emnay advised Auctus Capital Partners/Pharmalex. AmerisourceBergen Corporation (NYSE: ABC) signed a...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here